These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 20997191

  • 1. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    GOODMAN LS, WINTROBE MM.
    J Am Med Assoc; 1946 Sep 21; 132():126-32. PubMed ID: 20997191
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system.
    JACOBSON LO, SPURR CL.
    J Am Med Assoc; 1946 Oct 05; 132():263-71. PubMed ID: 20997209
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
    MASOUREDIS SP, LOW-BEER BV, BIERMAN HR, CHERNEY LS, SHIMKIN MB.
    J Natl Cancer Inst; 1950 Oct 05; 11(2):289-300. PubMed ID: 14795186
    [No Abstract] [Full Text] [Related]

  • 7. [Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
    de LORENZO J, JANNINI P.
    Arq Clin (Rio De J); 1951 Mar 05; 12(3):141-61. PubMed ID: 14847898
    [No Abstract] [Full Text] [Related]

  • 8. [The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
    RABENKO J, CORREA URQUIZA LM.
    Prensa Med Argent; 1959 Oct 09; 46():2549-54. PubMed ID: 14435621
    [No Abstract] [Full Text] [Related]

  • 9. Nitrogen mustards in the treatment of neoplastic disease.
    KARNOFSKY DA.
    Adv Intern Med; 1950 Oct 09; 4():1-75. PubMed ID: 14770961
    [No Abstract] [Full Text] [Related]

  • 10. Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
    SHERRY M.
    South Med J; 1948 Feb 09; 41(2):118-29. PubMed ID: 18898249
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A new derivative of yperite for oral and intramuscular administration: bis-(2-chloroethyl) beta-naphthylamine in cancer].
    RAMIOUL H.
    Acta Clin Belg; 1954 Feb 09; 9(5):401-63. PubMed ID: 13217644
    [No Abstract] [Full Text] [Related]

  • 15. A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
    SPEAR PW, PATNO ME.
    Cancer Chemother Rep; 1962 Feb 09; 16():413-5. PubMed ID: 13915594
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    SAMPEY JR.
    J S C Med Assoc (Columbia); 1962 May 09; 58():175-6. PubMed ID: 14496660
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.